Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells

The development of drug resistance in lung cancer is a major clinical challenge, leading to a 5-year survival rate of only 18%. Therefore, unravelling the mechanisms of drug resistance and developing novel therapeutic strategies is of crucial importance. This study systematically explores the novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Efeoglu, Esen, Henry, Michael, Clynes, Martin, Meleady, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599763/
https://www.ncbi.nlm.nih.gov/pubmed/36291610
http://dx.doi.org/10.3390/biom12101401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599763/
https://www.ncbi.nlm.nih.gov/pubmed/36291610
http://dx.doi.org/10.3390/biom12101401

Ejemplares similares